First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Recruiting · NCT07527923 · Registry updated 2026-10-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder | Recruiting | Phase 1 | 2026-10-07 | NCT07527923 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Regeneron Pharmaceuticals | 238 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Alliance Clinical West Hills (Focus Clinical Research) | West Hills | United States | 4 |
| Arkansas Research Trials | North Little Rock | United States | 7 |
| Cahaba Dermatology & Skin Health Center, LLC | Birmingham | United States | 5 |
| Center for Clinical Pharmacology University Hospitals Leuven (UZ Leuven) | Leuven | Belgium | 1 |
| Florida International Research Center | Miami | United States | 5 |
| National Allergy and Asthma Research, LLC | North Charleston | United States | 1 |
| Texas Dermatology and Laser Specialists | San Antonio | United States | 25 |